CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
40.71
+2.71 (7.13%)
At close: Oct 8, 2025, 4:00 PM EDT
41.11
+0.40 (0.98%)
After-hours: Oct 8, 2025, 7:54 PM EDT

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
3,1042,183---
Enterprise Value
2,4441,643---
Last Close Price
40.7128.68---
PS Ratio
5633.461916.94---
PB Ratio
4.632.98---
P/TBV Ratio
4.632.98---
EV/Sales Ratio
4435.541442.48---
Debt / Equity Ratio
0.0000.000.130.38
Asset Turnover
-0.000.000.00-
Quick Ratio
21.7834.7613.179.328.97
Current Ratio
22.1535.3013.629.549.78
Return on Equity (ROE)
--19.18%-31.36%-42.85%-
Return on Assets (ROA)
--15.02%-19.97%-21.34%-
Return on Capital (ROIC)
--15.60%-21.24%-22.42%-
Earnings Yield
-4.13%-4.03%---
FCF Yield
-3.03%-3.62%---
Buyback Yield / Dilution
-376.91%-1343.03%-15.77%-2.48%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q